CANNABICHROMENE AS A THERAPEUTIC MODALITY FOR COVID-19 Application US-20230000818-A1 United States of America 05 Jan 2023
COMPOSITIONS COMPRISING TETRAHYDROCANNABINOL FOR TREATING ACUTE RESPIRATORY FAILURE AND/OR… Application WO-2022094330-A3 World Intellectual Property Organisation (WIPO) 21 Jul 2022